Clinical Trials Browser

Phase 2 × Disease × Docetaxel × Clear all

NCT00571675 2010-11-09

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

Disease, Neoplasm Metastasis, Prostatic Neoplasms